Larkin Finbar has filed 5 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 4373 shares of Jazz Pharmaceuticals plc ($JAZZ) on March 03, 2023.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2023 | Jazz Pharmaceuticals plc | $JAZZ | Larkin Finbar | SVP, Technical Operations | A | Ordinary Shares | 4373 | $0.00 | 23,854.0000 | 62,539,000 | 22.45% | 0.01% |
| March 6, 2023 | Jazz Pharmaceuticals plc | $JAZZ | Larkin Finbar | SVP, Technical Operations | M | Ordinary Shares | 1706 | $58.72 | 25,560.0000 | 62,539,000 | 7.15% | 0.00% |
| March 6, 2023 | Jazz Pharmaceuticals plc | $JAZZ | Larkin Finbar | SVP, Technical Operations | S | Ordinary Shares | 1706 | $143.92 | 23,854.0000 | 62,539,000 | 6.67% | 0.00% |
| March 7, 2023 | Jazz Pharmaceuticals plc | $JAZZ | Larkin Finbar | SVP, Technical Operations | S | Ordinary Shares | 2075 | $140.76 | 21,779.0000 | 62,539,000 | 8.70% | 0.00% |
| March 6, 2023 | Jazz Pharmaceuticals plc | $JAZZ | Larkin Finbar | SVP, Technical Operations | M | Non-Qualified Stock Option (right to buy) | 1706 | $0.00 | 0.0000 | 62,539,000 | 100.00% | 0.00% |